# Urokinase

## UROKINASE 60,000IU

| TAH Drug Code      | [IUROK](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IUROK)                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute coronary embolism, clearance of occluded catheters & shunts, acute pulmonary embolism, peripheral arterial or venous thromboembolism.                                                                                                             |
| Dosing             | 60000-240000 IU on the first day, then decrease the dose day by day for about 7 days.                                                                                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                           |
| Contraindications  | Intracranial hemorrhage, hemoptysis, difficulty in hemostatic management; undergone intracranial or spinal surgery or with such injury (in the last 2 months); aneurysm; serious disturbance of consciousness.                                          |
| Adverse Effects    | Bleeding tendency. Fever, chills, headache & malaise may occur. Rarely, shock, sweating, disturbed pulse & dyspnea; rash, urticaria;nausea; vomiting & anorexia; abnormal liver function test; hematuria. Hematologic: Decreased hematocrit level (37%) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/urokinase-drug-information)                                                                                                                                                                                |

